Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin

被引:25
|
作者
Bernardes, Gabriel [1 ]
IJzerman, Richard G. [2 ]
ten Kulve, Jennifer S. [2 ]
Barkhof, Frederik [3 ,4 ,5 ]
Diamant, Michaela [2 ]
Veltman, Dick J. [6 ]
Landeira-Fernandez, Jesus [1 ]
van Bloemendaal, Liselotte [2 ]
van Duinkerken, Eelco [1 ,2 ,7 ,8 ]
机构
[1] Pontificia Univ Catolica Rio de Janeiro, Dept Psychol, Rua Marques de Sao Vincente 225, BR-22451900 Rio De Janeiro, RJ, Brazil
[2] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam Diabet Ctr, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[4] UCL, Inst Neurol, London, England
[5] UCL, Inst Healthcare Engn, London, England
[6] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[7] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands
[8] Inst Estadual Cerebro Paulo Niemeyer, Ctr Epilepsy, Rio De Janeiro, RJ, Brazil
关键词
Obesity; Type; 2; diabetes; Neuroimaging; Brain structure; Insulin; Glucose; BRAIN; THICKNESS; MELLITUS; VOLUMES;
D O I
10.1007/s11011-018-0223-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2DM) is associated with structural cortical and subcortical alterations, although it is insufficiently clear if these alterations are driven by obesity or by diabetes and its associated complications. We used FreeSurfer5.3 and FSL-FIRST to determine cortical thickness, volume and surface area, and subcortical gray matter volume in a group of 16 normoglycemic obese subjects and 28 obese T2DM patients without clinically manifest micro- and marcoangiopathy, and compared them to 31 lean normoglycemic controls. Forward regression analysis was used to determine demographic and clinical correlates of altered (sub)cortical structure. Exploratively, vertex-wise correlations between cortical structure and fasting glucose and insulin were calculated. Compared with controls, obese T2DM patients showed lower right insula thickness and lower left lateral occipital surface area (P (FWE) < 0.05). Normoglycemic obese versus controls had lower thickness (P (FWE) < 0.05) in the right insula and inferior frontal gyrus, and higher amygdala and thalamus volume. Thalamus volume and left paracentral surface area were also higher in this group compared with obese T2DM patients. Age, sex, BMI, fasting glucose, and cholesterol were related to these (sub)cortical alterations in the whole group (all P < 0.05). Insulin were related to temporal and frontal structural deficits (all P (FWE) < 0.05). Parietal/occipital structural deficits may constitute early T2DM-related cerebral alterations, whereas in normoglycemic obese subjects, regions involved in emotion, appetite, satiety regulation, and inhibition were affected. Central adiposity and elevated fasting glucose may constitute risk factors.
引用
收藏
页码:1211 / 1222
页数:12
相关论文
共 50 条
  • [21] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
    Schmid, C.
    Krayenbuhl, P.
    Wiesli, P.
    DIABETOLOGIA, 2009, 52 (12) : 2668 - 2669
  • [22] Leptin predicts cortical and subcortical gray matter volume recovery in alcohol dependent patients: A longitudinal structural magnetic resonance imaging study
    Bach, Patrick
    Koopmann, Anne
    Bumb, J. Malte
    Vollstaedt-Klein, Sabine
    Reinhard, Iris
    Rietschel, Marcella
    Witt, Stephanie H.
    Wiedemann, Klaus
    Kiefer, Falk
    HORMONES AND BEHAVIOR, 2020, 124
  • [23] Accelerated executive functions decline and gray matter structural changes in middle-aged type 1 diabetes mellitus patients with proliferative retinopathy
    van Duinkerken, Eelco
    Steenwijk, Martijn D.
    Klein, Martin
    Barkhof, Frederik
    Mograbi, Daniel C.
    Diamant, Michaela
    Snoek, Frank J.
    Ijzerman, Richard G.
    JOURNAL OF DIABETES, 2018, 10 (11) : 835 - 846
  • [24] Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes
    Buch, HN
    Baskar, V
    Barton, DM
    Kamalakannan, D
    Akarca, C
    Singh, BM
    DIABETIC MEDICINE, 2002, 19 (07) : 572 - 574
  • [25] Relationship Between Four Non-Insulin-Based Indexes of Insulin Resistance and Serum Uric Acid in Patients with Type 2 Diabetes: A Cross-Sectional Study
    Han, Rongfeng
    Zhang, Yang
    Jiang, Xia
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1461 - 1471
  • [26] Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance
    Fujinami, Aya
    Ohta, Kiyoe
    Obayashi, Hiroshi
    Fukui, Michiaki
    Hasegawa, Goji
    Nakamura, Naoto
    Kozai, Hana
    Imai, Saeko
    Ohta, Mitsuhiro
    CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) : 812 - 817
  • [27] The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance
    Kirkham, S.
    Akilen, R.
    Sharma, S.
    Tsiami, A.
    DIABETES OBESITY & METABOLISM, 2009, 11 (12) : 1100 - 1113
  • [28] Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes
    Jones, TA
    Sautter, M
    Van Gaal, LF
    Jones, NP
    DIABETES OBESITY & METABOLISM, 2003, 5 (03) : 163 - 170
  • [29] Preoperative insulin therapy as a marker for type 2 diabetes remission in obese patients after bariatric surgery
    Hariri, Kamyar
    Guevara, Daniela
    Jayaram, Anusha
    Kini, Subhash U.
    Herron, Daniel M.
    Fernandez-Ranvier, Gustavo
    SURGERY FOR OBESITY AND RELATED DISEASES, 2018, 14 (03) : 332 - 337
  • [30] A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes
    Stork, Alexander D. M.
    Erkelens, D. Willem
    Veneman, Thiemo F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (03) : 251 - 257